Small Molecules
25 July 2024
Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma23 July 2024
Enterprise Therapeutics Doses First Person with Cystic Fibrosis in Phase 2 Trial for Novel Therapy ETD00116 July 2024
Evommune Announces Positive Proof-of-Concept Clinical Trial Results for its MRGPRX2 Antagonist (EVO756)13 July 2024
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis12 July 2024
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist DanuglipronNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports